Bill Buxton is the author of, Sketching User Experiences: Getting the Design Right and the Right Design, published jointly by Morgan Kaufmann and Focal Press as well as a columnist on design and innovation for BusinessWeek.com. He is Principal Researcher at Microsoft Research and has a 30 year involvement in research, design and commentary around human aspects of technology, and digital tools for creative endeavour, including music, film and industrial design. Prior to joining Microsoft, he was a researcher at Xerox PARC, a professor at the University of Toronto, and Chief Scientist of Alias Research and SGI Inc. where in 2003 he was co-recipient of an Academy Award for Scientific and Technical Achievement.

In 2007, he was named Doctor of Design, honoris causa, by the Ontario College of Art and Design, in 2008 became the 10th reci-pient of the ACM/SIGCHI Lifetime Achievement Award for fundamental contributions to the field of human-computer interaction. In January 2009 was elected a Fellow of the ACM, in June was awarded a Doctor of Laws, honoris causa, by his alma mater, Queen's University, Kingston, Ontario, and in November was awarded an honourary doctorate in Industrial Design from the Technical University of Eindhoven, the Netherlands.

GlaxoSmithKline is a research-based pharmaceutical company that constantly strives to develop and produce vaccinations, medicines, as well as other health care products. GSK has also been identified as one of the 50 best companies to work for in Canada. GSK will address delegates about what they do as a for-profit health care company to sustain their business for future success.

Local Health Integration Networks are a series of not-for-profit organizations all across Ontario. They are responsible for the planning, funding and execution of integrating the health services within the given geographic region. The WWLHIN will address delegates about how specifically a not-for-profit health care business operates to ensure success for tomorrow.

Innomar Strategies provides a very diverse range consulting services to both pharmaceutical manufactures as well as to the health care community. This includes clinical development to patient assistance programs. Innomar will address the differences between profit and not-for profit companies from a consulting perspective. It will also touch on how Innomar has achieved its position within both.

Brookfield Renewable Power has the capacity to produce approximately 4,000 megawatts. This is accomplished from over 160 generating facilities. Brookfield has numerous developmental projects in both wind and hydroelectric power generation. Brookfield will address delegates about different types of renewable energy sources, and the strategies associated with sustaining a business of this nature.

Ontario Power Authority leads the province to achieve an electricity system that is reliable, cost-effective, and sustainable. This is accomplished by attaining a diverse range of electrical supply. OPA will address delegates about various types of power generation, as well as both the current supply of energy, and the long-term plan for electricity supply in Ontario.

IBM Canada Ltd. is one of Canada's leading providers of advanced information technology, products, services and business consulting expertise. IBM is one of Canada's top contributors to R&D investment. In 2008, IBM Canada invested $397 million (CDN) in R&D. IBM Will address the importance of R&D in a tech based company and identify why their R&D department is critical to the success of their business.

Tech Capital is a venture capital firm focused on helping entrepreneurs build world-class technology companies. Tech capital offers everything from financial support, to hands-on assistance, as well as a network of contacts. Tech Capital will address delegates about the factors involved with starting up a tech company, as well as how a successful start-up is a critical factor in the growing success of the business.

GABAE develops new technologies, processes and products spanning diverse industrial segments. GABAE has a diverse group of individuals including chemists, engineers, and machinists, all contributing to high-tech projects. GABAE will address the factor of Strategic Partnerships, why companies consistently utilize them, and how they've played, and will continue to play a crucial role in the success of GABAE.